All News about Alkermes Plc
Ketamine’s Potential As A Treatment For Depression Has Drawn Major Industry Attention
October 27, 2021
Exposures
Product Safety
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/styles/400w/public/videos/thumbnails/832281/thumbnail-832281_0001.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech3_1.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU5.jpg)
![](https://www.investors.com/wp-content/uploads/2018/11/Stock-DrugsWheel-01-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2017/06/IT03_cancer_050517_adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://www.investors.com/wp-content/uploads/2019/07/stock-pharmaceutical-opioids-01-shutter.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_378.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_375.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/092221_-_Alkermes_-_Alcohol_-_1632310566835.jpg)
New Survey Provides Insights Into Drinking Behaviors During the Pandemic
September 22, 2021
Via 3BL Media
Exposures
COVID-19
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU77.jpg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/styles/400w/public/videos/thumbnails/840896/thumbnail-840896_0006.png)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/styles/400w/public/videos/thumbnails/841776/thumbnail-841776_0014.png)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/bulls_bears4.png?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/waltham.png?width=720)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_300.jpeg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_808.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_368.jpg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/styles/400w/public/videos/thumbnails/832376/thumbnail-832376_0001.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_90.jpg)
Via Benzinga
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/081821_-_Alkermes_-_KeepWell_-_1628769847151.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_367.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_88.jpg)
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.